Cargando…

C-X-C-Chemokine-Receptor-Type-4 Inhibitor AMD3100 Attenuates Pulmonary Inflammation and Fibrosis in Silicotic Mice

BACKGROUND: Silicosis is a severe pulmonary disease caused by inhaling dust containing crystalline silica. The progression of silicosis to pulmonary fibrosis is usually unavoidable. Recent studies have revealed positivity for the overexpression of C-X-C chemokine receptor type 4 (CXCR4) in pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Qixian, Tao, Xinrong, Li, Bing, Cao, Hangbing, Chen, Haoming, Zou, Yuanjie, Tao, Huihui, Mu, Min, Wang, Wenyang, Xu, Keyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553317/ https://www.ncbi.nlm.nih.gov/pubmed/36238768 http://dx.doi.org/10.2147/JIR.S372751

Ejemplares similares

Inflammation and fibrosis in the coal dust-exposed lung described by confocal Raman spectroscopy
por: Wang, Wenyang, et al.
Publicado: (2022)

Coal dust exposure triggers heterogeneity of transcriptional profiles in mouse pneumoconiosis and Vitamin D remedies
por: Mu, Min, et al.
Publicado: (2022)

AMD3100/CXCR4 Inhibitor
por: De Clercq, Erik
Publicado: (2015)

Treatment with AMD3100 attenuates the microglial response and improves outcome after experimental stroke
por: Walter, Helene L, et al.
Publicado: (2015)

Synthesis and Evaluation of [(67)Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4
por: Aghanejad, Ayuob, et al.
Publicado: (2014)

MOBILIZATION STUDIES IN COMPLEMENT-DEFICIENT MICE REVEAL THAT OPTIMAL AMD3100 MOBILIZATION OF HEMATOPOIETIC STEM CELLS DEPENDS ON COMPLEMENT CASCADE ACTIVATION BY AMD3100-STIMULATED GRANULOCYTES
por: Lee, HakMo, et al.
Publicado: (2009)

AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
por: Yu, M, et al.
Publicado: (2011)

Oxamate Attenuates Glycolysis and ER Stress in Silicotic Mice
por: Mao, Na, et al.
Publicado: (2022)

Inhibition of CXCR4 in Spinal Cord and DRG with AMD3100 Attenuates Colon-Bladder Cross-Organ Sensitization
por: Zhang, Hengshuai, et al.
Publicado: (2022)

CXCR4 Antagonist AMD3100 Modulates Claudin Expression and Intestinal Barrier Function in Experimental Colitis
por: Xia, Xian-Ming, et al.
Publicado: (2011)

CXCR4 inhibition with AMD3100 attenuates amphetamine induced locomotor activity in adolescent Long Evans male rats
por: Mason, Briana, et al.
Publicado: (2021)

Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice
por: Liu, Tao, et al.
Publicado: (2016)

AMD3100 is a potent antagonist at CXCR4(R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome
por: McDermott, David H, et al.
Publicado: (2011)

CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice
por: Nishimura, Yukihide, et al.
Publicado: (2011)

Combinatorial G-CSF/AMD3100 Treatment in Cardiac Repair after Myocardial Infarction
por: Rüder, Constantin, et al.
Publicado: (2014)

VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing
por: Meeson, Richard, et al.
Publicado: (2018)

CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation
por: Zhou, Jun, et al.
Publicado: (2020)

Serum Levels of Copper, Ceruloplasmin and Angiotensin Converting Enzyme among Silicotic and Non-Silicotic Workers
por: Beshir, Safia, et al.
Publicado: (2015)

Alpha-tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation combined injury in mice
por: Singh, Vijay K., et al.
Publicado: (2014)

AMD3100 inhibits the migration and differentiation of neural stem cells after spinal cord injury
por: Liu, Jia-Ming, et al.
Publicado: (2017)

Functional Phenotypes of Peritoneal Macrophages Upon AMD3100 Treatment During Colitis-Associated Tumorigenesis
por: Wu, Shuai, et al.
Publicado: (2022)

Maternal Nicotine Exposure Alters Hippocampal Microglia Polarization and Promotes Anti-inflammatory Signaling in Juvenile Offspring in Mice
por: Zhou, Li, et al.
Publicado: (2021)

Influence of the interaction between Ac-SDKP and Ang II on the pathogenesis and development of silicotic fibrosis
por: Zhang, Yi, et al.
Publicado: (2018)

Effect of Sex Differences in Silicotic Mice
por: Jin, Fuyu, et al.
Publicado: (2022)

The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro
por: Kim, Ha-Yon, et al.
Publicado: (2010)

[(18)F]DPA-714 PET Imaging of AMD3100 Treatment in a Mouse Model of Stroke
por: Wang, Yu, et al.
Publicado: (2014)

AMD3100 improves ovariectomy-induced osteoporosis in mice by facilitating mobilization of hematopoietic stem/progenitor cells
por: Im, Jin Young, et al.
Publicado: (2014)

Effect of Endogenous Bone Marrow Derived Stem Cells Induced by AMD-3100 on Expanded Ischemic Flap
por: Jeong, Hii-Sun, et al.
Publicado: (2014)

Administration of AMD3100 in endotoxemia is associated with pro-inflammatory, pro-oxidative, and pro-apoptotic effects in vivo
por: Seemann, Semjon, et al.
Publicado: (2016)

Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration
por: De Clercq, Erik
Publicado: (2019)

Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation
por: Yang, Juan, et al.
Publicado: (2016)

Lupus Pleuritis with Silicotic Nodules in the Parietal Pleura
por: Tsuchiya, Kazuo, et al.
Publicado: (2017)

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
por: Broxmeyer, Hal E., et al.
Publicado: (2005)

Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model
por: Kang, Yubin, et al.
Publicado: (2010)

MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias
por: Spinello, I, et al.
Publicado: (2011)

Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)—Polish compassionate use experience
por: Basak, Grzegorz Wladyslaw, et al.
Publicado: (2010)

V3-Independent Competitive Resistance of a Dual-X4 HIV-1 to the CXCR4 Inhibitor AMD3100
por: Maeda, Yosuke, et al.
Publicado: (2014)

Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS
por: Rabinovich-Nikitin, Inna, et al.
Publicado: (2016)

Association of spirometric restriction with mortality in the silicotics: a cohort study
por: Yang, Shuyuan, et al.
Publicado: (2023)

HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration, and invasion in lung cancer
por: Muralidharan, Ranganayaki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vbgnced72f65c4ec2qk7e07mu9